Report copyright - TAKEDA ONCOLOGY · 2018. 10. 11. · in oncology • Compelling pre -clinical data; Phase 1 enrolling for patients with refractory multiple myeloma TAK-573 • A fully human, anti-
Please pass captcha verification before submit form
Please pass captcha verification before submit form